Basics Axogen, Inc. Common Stock AxoGen Inc is a medical technology company dedicated to peripheral nerve repair. It provide products and education to improve surgical treatment algorithms for peripheral nerve injuries. IPO Date: January 1, 1987 Sector: Healthcare Industry: Health Care Equipment and Supplies Market Cap: $1.42B Activated in VL: True Average Daily Range Avg Daily Range: $0.31 | 2.45% Avg Daily Range (30 D): $0.67 | 2.12% Avg Daily Range (90 D): $0.51 | 2.14% Institutional Daily Volume Avg Daily Volume: .27M Avg Daily Volume (30 D): .73M Avg Daily Volume (90 D): .75M Trade Size Avg Trade Size (Sh.): 90 Avg Trade Size (Sh.) (30 D): 60 Avg Trade Size (Sh.) (90 D): 68 Institutional Trades Total Inst.Trades: 1,343 Avg Inst. Trade: $1.36M Avg Inst. Trade (30 D): $1.91M Avg Inst. Trade (90 D): $1.8M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.44M Avg Closing Trade (30 D): $3.08M Avg Closing Trade (90 D): $2.24M Avg Closing Volume: 81.78K     News Jan 12, 2026 @ 12:00 PM Axogen, Inc. Reports Preliminary Unaudited Revenue... Source: Na Dec 4, 2025 @ 1:01 AM Axogen Announces FDA Approval of Biologics License... Source: Axogen, Inc. Oct 1, 2025 @ 2:50 PM AXGN Investors Have Opportunity to Join Axogen, In... Source: Business Wire Jul 30, 2025 @ 5:00 PM Global Amniotic Membrane Market Poised for Extraor... Source: Delveinsight Feb 11, 2025 @ 9:58 PM Axogen, Inc. to report 2024 fourth quarter and ful... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $.02 $.01 $-.08 Diluted EPS $.01 $.01 $-.08 Revenue $ 60.08M $ 56.66M $ 48.56M Gross Profit $ 45.99M $ 42.02M $ 34.93M Net Income / Loss $ .71M $ .58M $ -3.83M Operating Income / Loss $ 1.91M $ 1.67M $ -1.66M Cost of Revenue $ 14.09M $ 14.64M $ 13.63M Net Cash Flow $ 1.87M $ 1.94M $ -9.46M PE Ratio 3,130.00